QUANTITATIVE CHARACTERIZATION AND POTENTIAL FUNCTION OF MEMBRANE FAS APO-1 (CD95) RECEPTORS ON LEUKEMIC-CELLS FROM CHRONIC B-LYMPHOID AND T-LYMPHOID LEUKEMIAS/
S. Kamihira et al., QUANTITATIVE CHARACTERIZATION AND POTENTIAL FUNCTION OF MEMBRANE FAS APO-1 (CD95) RECEPTORS ON LEUKEMIC-CELLS FROM CHRONIC B-LYMPHOID AND T-LYMPHOID LEUKEMIAS/, British Journal of Haematology, 99(4), 1997, pp. 858-865
The expression and function of the Fas-receptor (Fas-R) were examined
in chronic lymphocytic leukaemia (CLL), hairy cell leukaemia-variant (
HCL-v) and adult T-cell leukaemia (ATL). The expression of Fas-R in fr
eshly isolated leukaemic cells was qualitatively and quantitatively di
fferent between each disease; faint in B-CLL, moderate in HCL-v and st
rong in ATL. Both full-length and alternatively spliced truncated form
s of Fas mRNA were detected even in CLL B cells with faint to negative
Fas-R, and Fas mRNA was also shown to be capable of increasing in vit
ro expression, i.e. the message was functional, Ln contrast, Fas-R exp
ression on ATL cells was heterogenous and usually intense with a mean
density approximately 3-fold higher than that of normal T cells, Fas-R
was confirmed to have the potential function for anti-Fas monoclonal
antibody-mediated cell death in vitro in Fas-R+ ATL cells, The express
ion level of Fas-R on the cells was higher in chronic than acute ATL (
10360 v 6260 antibody-binding capacity per cell, mFas(ABC); P<0.05) an
d was inversely correlated with serum LDH activity, suggesting that th
e strong Fas-R accounts for the slow progression of chronic ATL and th
e negative Fas-R protects from Fas-mediated cell death. These results
show that Fas-R expression on leukaemic cells is valuable in their cha
racterization and perhaps their function, and may contribute to the pr
ogression and immune evasion of malignant clones.